[Evaluation of the immunoenzyme test (Elisa) in detecting Clostiridium difficile toxin A in fecal samples].
Currently, the method of choice in diagnosis of Clostridium difficile-associated intestinal diseases is the detection of toxin B in fecal specimens. This method is long (72 h) and can be realized in laboratories which have tissue culture facilities. Commercial agglutination test have been evaluated but they lack in specificity. An immunoenzymatic test has been recently commercialized for detection of toxin A. We have compared the results of this assay on 275 fecal specimens from patients suspected of having Clostridium difficile-associated intestinal diseases with the results obtained with the cytotoxicity test and the culture. Of the 275 fecal specimens, 58 were positive in cytotoxicity and 53 in Elisa. The overall sensitivity and specificity of the Elisa compared with cytotoxicity were 89.5% and 99.0% respectively. The immunoenzymatic test detecting Clostridium difficile toxin A is an easy test to perform in 2 h 15; it displays a good correlation with detection of toxin B and can be very useful in daily laboratory diagnosis.
Barbut
F
F
Service de bactériologie-virologie, hôpital Saint-Antoine, Paris, France.
Caburet
F
F
Petit
J C
JC
D001427:Bacterial Toxins / Q000032:analysis*; D016360:Clostridioides difficile / Q000737:chemistry*; D003601:Cytotoxicity Tests, Immunologic / Q000379:methods; D003967:Diarrhea / Q000382:microbiology; D004797:Enzyme-Linked Immunosorbent Assay; D005069:Evaluation Studies as Topic; D005243:Feces / Q000737:chemistry* / Q000382:microbiology; D006801:Humans
D001427:Bacterial Toxins
Evaluation d'un test immunoenzymatique (Elisa) détectant la toxine A de Clostridium difficile dans des échantillons de selles.